Abstract

Asthma pathogenesis is complex and involves the interplay of many factors and actions. Airway inflammation in allergic asthma is characterized by an exaggerated activation of T helper type 2 cells, IgE production and infiltration and activation of eosinophils. The results of studies conducted in recent years indicate that the deficit of naturally occurring Foxp3+CD25+CD4+ and Foxp3+CD25+CD8+ regulatory T cells and type 1 regulatory T cells plays a pivotal role in the development of this disease. Moreover, numerous studies have provided convincing evidence that a decrease in IL-10 production and an increase in IL-17 production have an important place in the pathophysiology of asthma. TGF-β is another important cytokine involved in this disease. TGF-β has a paradoxical status in relation to asthma pathogenesis because it seems to play a role in both suppressing and promoting asthma development. This review discusses briefly clinical and experimental data concerning the involvement of T regulatory cells and IL-10, IL-17 and TGF-β in the pathogenesis of asthma.

References

• 1. Agache I., Akdis C., Jutel M., Virchow J.C.: Untangling asthmaphenotypes and endotypes. Allergy, 2012; 67: 835-846
  Google Scholar
• 2. Agache I., Ciobanu C., Agache C., Anghel M.: Increased serumIL-17 is an independent risk factor for severe asthma. Respir. Med.,2010; 104: 1131-1137
  Google Scholar
• 3. Agarwal A., Singh M., Chatterjee B.P., Chauhan A., ChakrabortiA.: Interplay of T helper 17 cells with CD4+CD25high FOXP3+Tregs inregulation of allergic asthma in pediatric patients. Int. J. Pediatr.,2014; 2014: 636238
  Google Scholar
• 4. Akdis C.A.: Therapies for allergic inflammation: refining strategiesto induce tolerance. Nat. Med., 2012; 18: 736-749
  Google Scholar
• 5. Akdis C.A., Blesken T., Akdis M., Wüthrich B., Blaser K.: Role ofinterleukin 10 in specific immunotherapy. J. Clin. Invest., 1998; 102:98-106
  Google Scholar
• 6. Akdis M., Verhagen J., Taylor A., Karamloo F., Karagiannidis C.,Crameri R., Thunberg S., Deniz G., Valenta R., Fiebig H., Kegel C.,Disch R., Schmidt-Weber C.B., Blaser K., Akdis C.A.: Immune responsesin healthy and allergic individuals are characterized by a finebalance between allergen-specific T regulatory 1 and T helper 2cells. J. Exp. Med., 2004; 199: 1567-1575
  Google Scholar
• 7. Al-Ramli W., Préfontaine D., Chouiali F., Martin J.G., OlivensteinR., Lemière C., Hamid Q.: TH17-associated cytokines (IL-17A and IL–17F) in severe asthma. J. Allergy Clin. Immunol., 2009; 123: 1185-1187
  Google Scholar
• 8. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A.: CD4+C-D25high regulatory cells in human peripheral blood. J. Immunol.,2001; 167: 1245-1253
  Google Scholar
• 9. Barczyk A., Pierzchala W., Caramori G., Wiaderkiewicz R., KaminskiM., Barnes P.J., Adcock I.M.: Decreased percentage ofCD4+Foxp3+TGF-β+ and increased percentage of CD4+IL-17+ cells inbronchoalveolar lavage of asthmatics. J. Inflamm. 2014; 11: 22
  Google Scholar
• 10. Barczyk A., Pierzchala W., Sozanska E.: Interleukin-17 in sputumcorrelates with airway hyperresponsiveness to methacholine.Respir. Med., 2003; 97: 726-733
  Google Scholar
• 11. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., SavelkoulH.F., de Waal-Malefyt R., Coffman R.L., Hawrylowicz C.M., O’GarraA.: In vitro generation of interleukin 10-producing regulatory CD4+T cells is induced by immunosuppressive drugs and inhibited by Thelper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med., 2002;195: 603-616
  Google Scholar
• 12. Bullens D.M., Truyen E., Coteur L., Dilissen E., Hellings P.W.,Dupont L.J., Ceuppens J.L.: IL-17 mRNA in sputum of asthmatic patients:linking T cell driven inflammation and granulocytic influx?Respir. Res., 2006; 7: 135
  Google Scholar
• 13. Chakir J., Shannon J., Molet S. Fukakusa M., Elias J., LavioletteM., Boulet L.P., Hamid Q.: Airway remodeling-associated mediatorsin moderate to severe asthma: effect of steroids on TGF-β, IL-11,IL-17, and type I and type III collagen expression. J. Allergy Clin.Immunol., 2003; 111, 1293-1298
  Google Scholar
• 14. Chambers E.S., Suwannasaen D., Mann E.H., Urry Z., Richards D.F.,Lertmemongkolchai G., Hawrylowicz C.M.: 1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases thefrequency of Foxp3⁺regulatory T cells through preferential expansionand usage of interleukin-2. Immunology, 2014; 143: 52-60
  Google Scholar
• 15. Choi M.S., Park S., Choi T., Lee G., Haam K.K., Hong M.C., MinB.I., Bae H.: Bee venom ameliorates ovalbumin induced allergic asthmavia modulating CD4+CD25+ regulatory T cells in mice. Cytokine,2013; 61: 256-265
  Google Scholar
• 16. Corthay A.: How do regulatory T cells work? Scand. J. Immunol.,2009; 70: 326-336
  Google Scholar
• 17. Dao Nguyen X., Robinson D.S.: Fluticasone propionate increasesCD4+CD25+ T regulatory cell suppression of allergen-stimulatedCD4+CD25- T cells by an IL-10-dependent mechanism. J. Allergy Clin.Immunol., 2004; 114: 296-301
  Google Scholar
• 18. Eusebio M., Kraszula L., Kupczyk M., Kuna P., Pietruczuk M.: Lowfrequency of CD8+CD25+FOXP3BRIGHT T cells and FOXP3 mRNAexpression in the peripheral blood of allergic asthma patients. J.Biol. Regul. Homeost. Agents, 2012; 26: 211-20
  Google Scholar
• 19. Fu C.L., Chuang Y.H., Chau L.Y., Chiang B.L.: Effects of adenovirus-expressingIL-10 in alleviating airway inflammation in asthma.J. Gene. Med., 2006; 8: 1393-1399
  Google Scholar
• 20. Fu C.L., Ye Y.L., Lee Y.L., Chiang B.L.: Effects of overexpression ofIL -10, IL-12, TGF-β and IL-4 on allergen induced change in bronchialresponsiveness. Respir. Res., 2006; 7: 72
  Google Scholar
• 21. GINA. http://www.ginasthma.org (05.12.2014)
  Google Scholar
• 22. Gorelik L., Flavell R.A.: Transforming growth factor-β in T-cellbiology. Nat. Rev. Immunol., 2002; 2: 46-53
  Google Scholar
• 23. Gu A.D., Wang Y., Lin L., Zhang S.S., Wan Y.Y.: Requirementsof transcription factor Smad-dependent and -independent TGF-βsignaling to control discrete T-cell functions. Proc. Natl. Acad. Sci.USA, 2012; 109: 905-910
  Google Scholar
• 24. Gupta A., Dimeloe S., Richards D.F., Chambers E.S., Black C., UrryZ., Ryanna K., Xystrakis E., Bush A., Saglani S., Hawrylowicz C.M.:Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatricsevere therapy-resistant asthma. Thorax, 2014; 69: 508-515
  Google Scholar
• 25. Hansen G., McIntire J.J., Yeung V.P., Berry G., Thorbecke G.J.,Chen L., DeKruyff R.H., Umetsu D.T.: CD4+ T helper cells engineeredto produce latent TGF-β1 reverse allergen-induced airway hyperreactivityand inflammation. J. Clin. Invest., 2000; 105: 61-70
  Google Scholar
• 26. Hawrylowicz C.M., O›Garra A.: Potential role of interleukin–10-secreting regulatory T cells in allergy and asthma. Nat. Rev.Immunol., 2005; 5: 271-283
  Google Scholar
• 27. Hawrylowicz C., Richards D., Loke T.K., Corrigan C., Lee T.: A defectin corticosteroid-induced IL-10 production in T lymphocytesfrom corticosteroid-resistant asthmatic patients. J. Allergy Clin.Immunol., 2002; 109: 369-370
  Google Scholar
• 28. Horbelt D., Denkis A., Knaus P.: A portrait of transforming growthfactor β superfamily signalling: Background matters. Int. J. Biochem.Cell Biol., 2012; 44: 469-474
  Google Scholar
• 29. Hori S., Nomura T., Sakaguchi S.: Control of regulatory T celldevelopment by the transcription factor Foxp3. Science, 2003; 299:1057-1061
  Google Scholar
• 30. Horwitz D.A., Zheng S.G., Wang J., Gray J.D.: Critical role of IL-2and TGF-β in generation, function and stabilization of Foxp3+CD4+Treg. Eur. J. Immunol., 2008; 38: 912-915
  Google Scholar
• 31. Huang H.R., Liu T.T.; Wei J., Mai X.D., Wu B.J., Tan W.P.: Changesof CD4+CD25+ regulatory T cells and their relation with the allergicphysique and the levels of IgE in peripheral blood of asthmatic children.Chin. J. Clinicians., 2004; 3: 780-784
  Google Scholar
• 32. Hus I., Maciąg E., Roliński J.: Znaczenie limfocytów Th17 w odpornościprzeciwnowotworowej. Postępy Hig. Med. Dośw., 2010;64: 244-250
  Google Scholar
• 33. John M., Lim S., Seybold J., Jose P, Robichaud A., O’Connor B.,Barnes P.J, Chung K.F.: Inhaled corticosteroids increase interleukin-10but reduce macrophage inflammatory protein-1α, granulocyte-macrophagecolony-stimulating factor, and interferon-g releasefrom alveolar macrophages in asthma. Am. J. Respir. Crit. CareMed., 1998; 157: 256-262
  Google Scholar
• 34. Joseph J., Benedict S., Badrinath P., Wassef S., Joseph M., AbdulkhalikS., Nicholls M.G.: Elevation of plasma transforming growthfactor β1 levels in stable nonatopic asthma. Ann. Allergy AsthmaImmunol., 2003; 91: 472-476
  Google Scholar
• 35. Jutel M.: Allergen-specific immunotherapy in asthma. Curr.Treat. Options Allergy, 2014; 1: 213-219
  Google Scholar
• 36. Jutel M., Akdis M., Budak F., Aebischer-Casaulta C., Wrzyszcz M.,Blaser K., Akdis C.A.: IL-10 and TGF-βcooperate in the regulatory Tcell response to mucosal allergens in normal immunity and specificimmunotherapy. Eur. J. Immunol., 2003; 33: 1205-1214
  Google Scholar
• 37. Karagiannidis C., Akdis M., Holopainen P., Woolley N.J., Hense G.,Ruckert B., Mantel P.Y., Menz G., Akdis C.A., Blaser K., Schmidt-WeberC.B.: Glucocorticoids upregulate FOXP3 expression and regulatoryT cells in asthma. J. Allergy Clin. Immunol., 2004; 114: 1425-1433
  Google Scholar
• 38. Karagiannidis C., Hense G., Martin C., Epstein M., Rückert B.,Mantel P.Y., Menz G., Uhlig S., Blaser K., Schmidt-Weber C.B.: ActivinA is an acute allergen-responsive cytokine and provides a linkto TGF-β-mediated airway remodeling in asthma. J. Allergy Clin.Immunol., 2006; 117: 111-118
  Google Scholar
• 39. Kawashima S., Hirose K., Iwata A., Takahashi K., Ohkubo A., TamachiT., Ikeda K., Kagami S., Nakajima H.: β-glucan curdlan inducesIL-10-producing CD4+ T cells and inhibits allergic airway inflammation.J. Immunol., 2012; 189: 5713-5721
  Google Scholar
• 40. Kawayama T., Matsunaga K., Kaku Y., Yamaguchi K., Kinoshita T.,O’Byrne P.M., Hoshino T.: Decreased CTLA4+ and Foxp3+CD25highCD4+cells in induced sputum from patients with mild atopic asthma. Allergol.Int., 2013; 62: 203-213
  Google Scholar
• 41. Kearley J., Barker J.E., Robinson D.S., Lloyd C.M.: Resolution ofairway inflammation and hyperreactivity after in vivo transfer ofCD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp.Med., 2005; 202: 1539-1547
  Google Scholar
• 42. Kearley J., Robinson D.S., Lloyd, C.M.: CD4+CD25+ regulatory Tcells reverse established allergic airway inflammation and preventairway remodeling. J. Allergy Clin. Immunol., 2008; 122: 617-624
  Google Scholar
• 43. Kokturk N., Tatlicioglu T., Memis L., Akyurek N., Akyol G.: Expressionof transforming growth factor β1 in bronchial biopsies in asthmaand COPD. J. Asthma, 2003; 40: 887-893
  Google Scholar
• 44. Kudo M., Ishigatsubo Y., Aoki I.: Pathology of asthma. Front.Microbiol., 2013; 4: 263
  Google Scholar
• 45. Kudo M., Melton A.C., Chen C., Engler M.B., Huang K.E., Ren X.,Wang Y., Bernstein X., Li J.T., Atabai K., Huang X., Sheppard D.: IL–17A produced by αβ T cells drives airway hyper-responsiveness inmice and enhances mouse and human airway smooth muscle contraction.Nat. Med., 2012; 18: 547-554
  Google Scholar
• 46. Langier S., Sade K., Kivity S.: Regulatory T cells in allergic asthma.Isr. Med. Assoc. J., 2012; 14: 180-183
  Google Scholar
• 47. Leech M.D., Benson R.A., De Vries A., Fitch P.M, Howie S.E.: Resolutionof Der p1-induced allergic airway inflammation is dependenton CD4+CD25+Foxp3+ regulatory cells. J. Immunol., 2007; 179:7050-7058
  Google Scholar
• 48. Lemanske R.F., Busse W.W.: Asthma: clinical expression and molecularmechanisms. J. Allergy Clin. Immunol., 2010; 125: S95-S102
  Google Scholar
• 49. Lewkowich I.P., Herman N.S., Schleifer K.W., Dance M.P., ChenB.L., Dienger K.M., Sproles A.A. Shah J.S., Köhl J., Belkaid Y., Wills–Karp M.: CD4+CD25+ T cells protect against experimentally inducedasthma and alter pulmonary dendritic cell phenotype and function.J. Exp. Med., 2005; 202: 1549-1561
  Google Scholar
• 50. Li M.O., Sanjabi S., Flavell R.A.: Transforming growth factor-βcontrols development, homeostasis, and tolerance of T cells by regulatoryT cell-dependent and -independent mechanisms. Immunity,2006; 25: 455-471
  Google Scholar
• 51. Ling E.M., Smith T., Nguyen X.D., Pridgeon C., Dallman M., ArberyJ., Carr V.A., Robinson D.S.: Relation of CD4+CD25+ regulatory T-cellsuppression of allergen-driven T-cell activation to atopic status andexpression of allergic disease. Lancet, 2004; 363: 608-615
  Google Scholar
• 52. Liu Y., Zhang P, Li J., Kulkarni A.B., Perruche S., Chen W.: A criticalfunction for TGF-β signaling in the development of naturalCD4+CD25+Foxp3+ regulatory T cells. Nat. Immunol., 2008; 9: 632-640
  Google Scholar
• 53. Maazi H., Shirinbak S., Willart M., Hammad H.M., Cabanski M.,Boon L., Ganesh V., Baru A.M., Hansen G., Lambrecht B.N., SparwasserT., Nawijn M.C., van Oosterhout A.J.: Contribution of regulatoryT cells to alleviation of experimental allergic asthma after specificimmunotherapy. Clin. Exp. Allergy, 2012; 42: 1519-1528
  Google Scholar
• 54. Mahon B.D., Gordon S.A., Cruz J., Cosman F., Cantorna M.T.: Cytokineprofile in patients with multiple sclerosis following vitaminD supplementation. J. Neuroimmunol., 2003; 134: 128-132
  Google Scholar
• 55. Makinde T., Murphy R.F., Agrawal D.K.: The regulatory role ofTGF-β in airway remodeling in asthma. Immunol. Cell Biol., 2007;85: 348-356
  Google Scholar
• 56. Mangan P.R., Harrington L.E., O›Quinn D.B., HelmsW.S., BullardD.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T.:Transforming growth factor-β induces development of the TH17lineage. Nature, 2006; 441: 231-234
  Google Scholar
• 57. Marwaha A.K., Leung N.J., McMurchy A.N., Levings M.K.: TH17cells in autoimmunity and immunodeficiency: protective or pathogenic?Front. Immunol., 2012; 3: 129
  Google Scholar
• 58. Maślanka T.: Komórki regulatorowe z populacji limfocytów CD4+.Med. Wet., 2010; 66: 827-832
  Google Scholar
• 59. Meiler F., Zumkehr J., Klunker S., Rückert B., Akdis C.A., AkdisM.: In vivo switch to IL-10-secreting T regulatory cells in high doseallergen exposure. J. Exp. Med., 2008; 205: 2887-2898
  Google Scholar
• 60. Molet S., Hamid Q., Davoine F., Nutku E., Taha R., Page N., OlivensteinR., Elias J., Chakir J.: IL-17 is increased in asthmatic airwaysand induces human bronchial fibroblasts to produce cytokines. J.Allergy Clin. Immunol., 2001; 108: 430-438
  Google Scholar
• 61. Moore K.W., de Waal Malefyt R., Coffman R.L., O’Garra A.: Interleukin-10and the interleukin-10 receptor. Annu. Rev. Immunol.,2001; 19: 683-765
  Google Scholar
• 62. Nakao A., Miike S., Hatano M., Okumura K., Tokuhisa T., Ra C.,Iwamoto I.: Blockade of transforming growth factor β/Smad signalingin T cells by overexpression of Smad7 enhances antigen-inducedairway inflammation and airway reactivity. J. Exp. Med., 2000;192: 151-158
  Google Scholar
• 63. Nakashima T., Hayashi T., Mizuno T.: Regulation of the developmentof asthmatic inflammation by in situ CD4+Foxp3+T cells in a mousemodel of late allergic asthma. Inflammation, 2014; 37: 1642-1653
  Google Scholar
• 64. Olsen P.C., Kitoko J.Z., Ferreira T.P., de-Azevedo C.T., Arantes A.C.,Martins M.A.: Glucocorticoids decrease Treg cell numbers in lungsof allergic mice. Eur. J. Pharmacol., 2015; 747: 52-58
  Google Scholar
• 65. Ouyang W., Beckett O., Ma Q., Li M.O.: Transforming growthfactor-β signaling curbs thymic negative selection promoting regulatoryT cell development. Immunity, 2010; 32: 642-653
  Google Scholar
• 66. Pace E., Di Sano C., La Grutta S., Ferraro M., Albeggiani G., LiottaG., Di Vincenzo S., Uasuf C.G., Bousquet J., Gjomarkaj M.: Multiple invitro and in vivo regulatory effects of budesonide in CD4+ T lymphocytesubpopulations of allergic asthmatics. PLoS One, 2012; 7: e48816
  Google Scholar
• 67. Park S.J., Lee Y.C.: Interleukin-17 regulation: an attractive therapeuticapproach for asthma. Respir. Res., 2010; 11: 78
  Google Scholar
• 68. Provoost S., Maes T., van Durme Y.M., Gevaert P., Bachert C.,Schmidt-Weber C.B., Brusselle G.G., Joos G.F., Tournoy K.G.: DecreasedFOXP3 protein expression in patients with asthma. Allergy,2009; 64: 1539-1546
  Google Scholar
• 69. Radulovic S., Jacobson M.R., Durham S.R., Nouri-Aria K.T.: Grasspollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cellsin the nasal mucosa. J Allergy Clin. Immunol., 2008; 121: 1467-1472
  Google Scholar
• 70. Raeiszadeh Jahromi S., Mahesh P.A., Jayaraj B.S., MadhunapantulaS.R., Holla A.D., Vishweswaraiah S., Ramachandra N.B.: Serumlevels of IL-10, IL-17F and IL-33 in patients with asthma: a case-controlstudy. J. Asthma, 2014; 51: 1004-1013
  Google Scholar
• 71. Robinson D.S.: The role of the T cell in asthma. J. Allergy Clin.Immunol., 2010; 126: 1081-1091
  Google Scholar
• 72. Roncarolo M. G., Bacchetta R., Bordignon C., Narula S., Levings,M. K.: Type 1 T regulatory cells. Immunol. Rev., 2001; 182: 68-79
  Google Scholar
• 73. Saxena A., Khosraviani S., Noel S., Mohan D., Donner T., HamadA.R.: Interleukin-10 paradox: a potent immunoregulatory cytokinethat has been difficult to harness for immunotherapy. Cytokine,2015; 74: 27-34
  Google Scholar
• 74. Scherf W., Burdach S., Hansen G.: Reduced expression of transforminggrowth factor β1 exacerbates pathology in an experimentalasthma model. Eur. J. Immunol., 2005; 35: 198-206
  Google Scholar
• 75. Schramm C., Herz U., Podlech J., Protschka M., Finotto S., ReddehaseM.J., Köhler H., Galle P.R., Lohse A.W., Blessing M.: TGF-β regulatesairway responses via T cells. J. Immunol., 2003; 170: 1313-1319
  Google Scholar
• 76. Shi Y.H., Shi G.C., Wan H.Y., Jiang L.H., Ai X.Y., Zhu H.X., TangW., Ma J.Y., Jin X.Y., Zhang B.Y.: Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chin. Med. J.,2011; 124: 1951-1956
  Google Scholar
• 77. Stelmaszczyk-Emmel A., Zawadzka-Krajewska A., Głodkowska–Mrówka E., Demkow U.: FoxP3 Tregs response to sublingual allergenspecific immunotherapy in children depends on the manifestationof allergy. J. Immunol. Res., 2015; 2015: 731381
  Google Scholar
• 78. Taher Y.A., van Esch B.C., Hofman G.A., Henricks P.A., van OosterhoutA.J.: 1α,25-dihydroxyvitamin D3 potentiates the beneficial effectsof allergen immunotherapy in a mouse model of allergic asthma:role for IL-10 and TGF-β. J. Immunol., 2008; 180: 5211-5221
  Google Scholar
• 79. Tang Q., Bluestone J.A.: The Foxp3+ regulatory T cell: a jack ofall trades, master of regulation. Nat. Immunol., 2008; 9: 239-244
  Google Scholar
• 80. Thunberg S., Gafvelin G., Nord M., Grönneberg R., GrunewaldJ., Eklund A., van Hage M.: Allergen provocation increases TH2-cytokinesand FOXP3 expression in the asthmatic lung. Allergy, 2010;65: 311-318
  Google Scholar
• 81. Urry Z., Xystrakis E., Richards D.F., McDonald J., Sattar Z., CousinsD.J., Corrigan C.J., Hickman E., Brown Z., Hawrylowicz C.M.:Ligation of TLR9 induced on human IL-10-secreting Tregs by 1α,25-dihydroxyvitamin D3 abrogates regulatory function. J. Clin. Invest.,2009; 119: 387-398
  Google Scholar
• 82. Wakashin H., Hirose K., Maezawa Y., Kagami S., Suto A., WatanabeN., Saito Y., Hatano M., Tokuhisa T., Iwakura Y., Puccetti P., IwamotoI., Nakajima H.: IL-23 and Th17 cells enhance Th2-cell-mediatedeosinophilic airway inflammation in mice. Am. J. Respir. Crit. CareMed., 2008; 178: 1023-1032
  Google Scholar
• 83. Wan Y.Y., Flavell R.A.: Identifying Foxp3-expressing suppressorT cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA, 2005;102: 5126-5131
  Google Scholar
• 84. Wilson R.H., Whitehead G.S., Nakano H., Free M.E., Kolls J.K.,Cook D.N.: Allergic sensitization through the airway primes Th17–dependent neutrophilia and airway hyperresponsiveness. Am. J.Respir. Crit. Care Med., 2009; 180: 720-730
  Google Scholar
• 85. Workman C.J., Szymczak-Workman A.L., Collison L.W., PillaiM.R., Vignali D.A.: The development and function of regulatory Tcells. Cell. Mol. Life Sci., 2009; 66: 2603-2622
  Google Scholar
• 86. Wu K., Bi Y., Sun K., Wang C.: IL-10-producing type 1 regulatoryT cells and allergy. Cell. Mol. Immunol., 2007; 4: 269-275
  Google Scholar
• 87. Xystrakis E., Kusumakar S., Boswell S., Peek E., Urry Z., RichardsD.F., Adikibi T., Pridgeon C., Dallman M., Loke T.K., Robinson D.S.,Barrat F.J., O’Garra A., Lavender P., Lee T.H., Corrigan C., HawrylowiczC.M.: Reversing the defective induction of IL-10-secreting regulatoryT cells in glucocorticoid-resistant asthma patients. J. Clin.Invest., 2006; 116: 146-155
  Google Scholar
• 88. Yang L., Ma Q., Yao W., Zhang Q., Chen H., Wang G., Wang C.:Relationship between the anti-inflammatory properties of salmeterol/fluticasoneand the expression of CD4+CD25+Foxp3+ regulatoryT cells in COPD. Respir. Res., 2011; 12: 142
  Google Scholar
• 89. Yang Y.L., Pan Y.Q., He B.S., Zhong T.Y.: Regulatory T cells andTh1/Th2 in peripheral blood and their roles in asthmatic children.Transl. Pediatr., 2013; 2: 27-33
  Google Scholar
• 90. Zhao J., Lloyd C.M., Noble A.: Th17 responses in chronic allergicairway inflammation abrogate regulatory T-cell-mediated toleranceand contribute to airway remodeling. Mucosal Immunol.,2013; 6: 335-346
  Google Scholar

Full text